ARTICLE | Distillery Therapeutics
Neurology
May 3, 2017 6:14 PM UTC
Mouse studies suggest inhibiting NOX1 could help treat depression. In two mouse models of depression, NOX1 knockdown decreased social avoidance and acute stress-induced immobility compared with normal expression. Next steps could include identifying and test NOX1 inhibitors in other models of depression...
BCIQ Company Profiles
BCIQ Target Profiles